Back to UBS Group AG UBS Group AG

CELZCELZ
13 quarters

Position history for UBS Group AGUBS Group AG's holdings in CREATIVE MED TECHNOLOGY HLDG

Yes. Ubs holds 2,061 shares of CELZ (Creative Med Technology), worth $2,989, as of its Q2 2026 13F filing. It increased the position from 1 shares in Q1 2026. Ubs has held CELZ since Q3 2024, across 8 quarterly 13F filings.

Current Value

$2,989

Current Shares

2,061

Total Value Change

+$2,896

Total Shares Change

+2,041

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2,061
+2060x
$2,9890.0%$1.45
14
2026-Q1
Decreased
1
-90.9%
$20.0%$2.06
0
2025-Q4
Increased
11
+450.0%
$220.0%$1.96
12
2025-Q3
Unchanged
2
0.0%
$70.0%$3.33
0
2025-Q2
Unchanged
2
0.0%
$50.0%$2.65
0
2025-Q1
Increased
2
+100.0%
$40.0%$2.17
12
2024-Q4
Decreased
1
-100.0%
$20.0%$2.31
0
2024-Q3
New
2,725
-
$8,4480.0%$3.10
25
2024-Q2
Exited
0
-100.0%
$00.0%$3.85
0
2024-Q1
Increased
3,064
+194.1%
$15,9630.0%$5.21
20
2023-Q4
Decreased
1,042
-4.6%
$4,8040.0%$4.61
0
2023-Q3
Increased
1,092
+5360.0%
$5,3730.0%$4.92
17
2023-Q2
New
20
-
$930.0%$4.64
17

Other major holders of CELZ: Hudson Bay Capital Management LP, VANGUARD GROUP INC, Virtu Financial LLC, GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used